Litcius/Paper detail

HER2 borderline is a negative prognostic factor for primary malignant breast cancer

Atanu Bhattacharjee, Jacinth Rajendra, Rajesh Dikshit, Shilpee Dutt

2020Breast Cancer Research and Treatment31 citationsDOI

Topics & Concepts

Breast cancerMedicineOncologyInternal medicineCancerRisk factorHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies
HER2 borderline is a negative prognostic factor for primary malignant breast cancer | Litcius